Checkpoint Therapeutics, Inc. (CKPT)
USD 3.57
(-3.9%)
USD 3.57
(-3.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -47.59 Million | -57.55 Million | -26.3 Million | -16.55 Million | -21.37 Million | -25.8 Million |
| Net Income | -51.84 Million | -62.62 Million | -56.67 Million | -23.08 Million | -24.71 Million | -36.36 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 2.89 Million | 2.92 Million | 3.13 Million | 2.78 Million | 3.12 Million | 1.99 Million |
| Change in working capital | -2.79 Million | -4.6 Million | 19.59 Million | -1.76 Million | -3.02 Million | 6 Million |
| Other non-cash items | 4.15 Million | 6.75 Million | 7.63 Million | 5.51 Million | 3.24 Million | 2.56 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 40.45 Million | 14.88 Million | 40.26 Million | 31.24 Million | 25.45 Million | 28.57 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -1.7 Million | - | - | - | - |
| Common Stock Issuance | 29.31 Million | 16.58 Million | 41.27 Million | 33.26 Million | 27.57 Million | 28.57 Million |
| Other Financing Activities | 40.45 Million | 16.59 Million | -1.01 Million | -2.02 Million | -2.11 Million | 28.57 Million |
| Accounts receivables | 73 Thousand | -56 Thousand | 3000.00 | 6000.00 | 1.5 Million | -1.2 Million |
| Accounts payables | -5.07 Million | -4.62 Million | 18.76 Million | -833 Thousand | -5.04 Million | 6.72 Million |
| Inventory | - | 56 Thousand | -3000.00 | -6000.00 | -1.5 Million | - |
| Other working capital | 2.2 Million | 14 Thousand | 831 Thousand | -935 Thousand | 2.01 Million | -716 Thousand |
| Cash at beginning of period | 12.06 Million | 54.73 Million | 40.77 Million | 26.07 Million | 21.99 Million | 19.22 Million |
| Cash at end of period | 4.92 Million | 12.06 Million | 54.73 Million | 40.77 Million | 26.07 Million | 21.99 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -7.14 Million | -42.66 Million | 13.96 Million | 14.69 Million | 4.08 Million | 2.77 Million |
| Free Cash Flow | -47.59 Million | -57.55 Million | -26.3 Million | -16.55 Million | -21.37 Million | -25.8 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.67 Million | -10.94 Million | -19.12 Million | -51.84 Million | -5.72 Million | -16.52 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.17 Million | 709 Thousand | 672 Thousand | 2.89 Million | 689 Thousand | 567 Thousand |
| Change in working capital | -741 Thousand | 3.36 Million | -901 Thousand | -2.79 Million | -7.99 Million | 3.21 Million |
| Other non-cash items | 1.96 Million | -2.54 Million | 12.52 Million | 4.15 Million | -1.71 Million | 759 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -50 Thousand | 12.78 Million | 9.98 Million | 40.45 Million | 9.1 Million | 14.55 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -12.78 Million | 14 Million | -1.14 Million | 29.31 Million | 9.1 Million | 14.55 Million |
| Other Financing Activities | -50 Thousand | -1.21 Million | 9.98 Million | 40.45 Million | 9.1 Million | 14.55 Million |
| Accounts receivables | -41 Thousand | - | 31 Thousand | 73 Thousand | - | 4000.00 |
| Accounts payables | -756 Thousand | 3.65 Million | -2.4 Million | -5.07 Million | -8.46 Million | 3.08 Million |
| Inventory | - | - | 1.5 Million | - | - | - |
| Other working capital | 56 Thousand | -284 Thousand | -35 Thousand | 2.2 Million | 471 Thousand | 129 Thousand |
| Cash at beginning of period | 11.24 Million | 4.92 Million | 1.77 Million | 12.06 Million | 7.42 Million | 4.84 Million |
| Cash at end of period | 4.95 Million | 11.24 Million | 4.92 Million | 4.92 Million | 1.77 Million | 7.42 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -6.29 Million | 6.31 Million | 3.15 Million | -7.14 Million | -5.64 Million | 2.57 Million |
| Free Cash Flow | -6.24 Million | -6.47 Million | -6.83 Million | -47.59 Million | -14.75 Million | -11.97 Million |
CASY
0J9P
BXBLY
IAM
2616
4931